Inventiva (IVA) Non Operating Interest Expenses (2019 - 2022)
Powered by 
Analysis
Inventiva (IVA) Non Operating Interest Expenses (2019 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Inventiva | 888.24 Mn | 888.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -180,583.78 |
| Sep 22, 2022 | 56,345.74 |
| Dec 31, 2021 | 93,805.62 |
| Jun 30, 2021 | -2.64 Mn |
| Mar 31, 2021 | -2.71 Mn |
| Dec 31, 2020 | 21,461.22 |
| Jun 30, 2020 | -30,840.88 |
| Mar 31, 2020 | -14,351.21 |
| Dec 31, 2019 | -46,489.28 |